Menu

AstraZeneca’s Breast Cancer Drug Shows Positive Results In Late-Stage Trial

AstraZeneca said its breast cancer drug candidate showed positive results in a late stage trial, with improved progression-free survival in patients.

The British pharma giant said Wednesday that the trial for Camizestrant showed statistically significant and clinically meaningful

Scroll to Top